.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Colorectal cancer (CRC) remains a significant public health burden. Unfortunately, many patients avoid traditional screening methods such as colonoscopy or stool-based tests. Blood-based CRC screening offers a non-invasive alternative that could improve population health outcomes. By providing a simpler testing modality, healthcare providers can reach individuals who previously declined all screening options. Consequently, this approach may significantly reduce cancer-related mortality in the long term.
This study utilized a validated discrete-event simulation model to assess 10,000 individuals starting at age 45. Researchers analyzed clinical outcomes and cost-effectiveness from a healthcare sector perspective. Evidence from randomized controlled trials informed patient preferences for various screening options. Furthermore, the researchers modeled adherence using both ideal and longitudinal real-world scenarios. The findings indicate that adding blood tests to the screening arsenal yields substantial benefits. Specifically, CRC deaths averted increased between 68% and 247% in revealed preference scenarios compared to no screening.
Cost-effectiveness remains a critical factor for implementing any new medical technology. The analysis found that blood tests fall well within the standard willingness-to-pay threshold of $100,000 per quality-adjusted life-year (QALY). Incremental cost-effectiveness ratios (ICERs) ranged from $30,464 to $85,497 across different scenarios. Therefore, these tests provide high value while addressing the screening gap. Additionally, the non-invasive nature of the test helps patients overcome common psychological and logistical barriers associated with colonoscopy.
Despite these promising results, some limitations exist. The study relied on informed assumptions for natural history and longitudinal adherence due to limited real-world data. However, the simulation demonstrates that blood-based CRC screening can lead to cost-effective increases in life-saving outcomes. Healthcare systems should consider these findings when developing inclusive screening programs for resistant populations.
No, it serves as an alternative for patients who decline traditional methods, helping to increase overall screening rates and catch cancer earlier.
Blood tests are cost-effective because they significantly increase screening participation among individuals who otherwise would not be screened at all, reducing long-term treatment costs.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new economic evaluation shows that blood-based colorectal cancer screening is cost-effective and significantly reduces mortality among unscreened individu...
5 months ago
A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today
A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today
Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
